Krensavage Asset Management, LLC Long-Term Concentrated

CIK: 0001609251 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 14, 2016

Total Value ($000): $276,731 (100.0% shares, 0.0% debt)

Holdings (17)

UTHR UNITED THERAPEUTICS CORP 11.8%
Value ($000) $32,562 Shares 275,764 Est. Cost $136.10 Unrealized -11.7%
OM2 ORTHOFIX INTERNATIONAL NV 9.9%
Value ($000) $27,366 Shares 639,851 Est. Cost $32.01 Unrealized
ENTA ENANTA PHARMACEUTICALS INC 9.6%
Value ($000) $26,603 Shares 999,741 Est. Cost $36.29 Unrealized -36.0%
IMPAX LABORATORIES INC 8.8%
Value ($000) $24,463 Shares 1,032,187 Est. Cost $30.42 Unrealized
AMGEN INC 7.6%
Value ($000) $21,024 Shares 126,038 Est. Cost $152.19 Unrealized
SUCAMPO PHARMACEUTICALS CL A 7.3%
Value ($000) $20,335 Shares 1,651,898 Est. Cost $12.18 Unrealized
HALYARD HEALTH INC 7.2%
Value ($000) $19,974 Shares 576,285 Est. Cost $40.74 Unrealized
INDIVIOR PLC 6.8%
Value ($000) $18,829 Shares 4,736,823 Est. Cost $3.34 Unrealized
TEVA TEVA PHARMACEUTICAL SP ADR 6.6%
Value ($000) $18,285 Shares 397,412 Est. Cost $58.35 Unrealized
MRK MERCK & CO INC 5.8%
Value ($000) $16,103 Shares 258,021 Est. Cost $39.26 Unrealized +11.4%
RTI SURGICAL INC 4.7%
Value ($000) $13,087 Shares 4,181,091 Est. Cost $4.41 Unrealized
CNMD CONMED CORP 4.7%
Value ($000) $13,051 Shares 325,785 Est. Cost $37.99 Unrealized +1.3%
INVACARE CORP 4.2%
Value ($000) $11,652 Shares 1,043,111 Est. Cost $14.06 Unrealized
AVIRAGEN THERAPEUTICS INC 1.9%
Value ($000) $5,210 Shares 2,713,517 Est. Cost $1.40 Unrealized
DERMA SCIENCES INC 1.5%
Value ($000) $4,128 Shares 884,000 Est. Cost $4.57 Unrealized
DIGIRAD CORP 0.9%
Value ($000) $2,459 Shares 482,121 Est. Cost $4.41 Unrealized
JUNIPER PHARMACEUTICALS INC 0.6%
Value ($000) $1,600 Shares 288,294 Est. Cost $9.19 Unrealized